Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that recognizing and treating cutaneous lupus erythematosus early is crucial for managing the skin and potential systemic symptoms.

Lupus affects the body and skin, causing joint pain and skin issues that can be treated with steroids and antimalarial drugs.

Some breast cancer chemotherapy can cause permanent hair loss.

A woman with a new PTCH gene mutation has both Gorlin syndrome and severe hair loss.

Any drug can cause skin reactions, but antibiotics, NSAIDs, and psychotropic drugs are more common, with some reactions being life-threatening.

Cutaneous angiosarcomas require a combined treatment approach, but prognosis is generally poor.

Creating stronger blockers for skin enzymes might lead to better treatment for conditions like acne and excessive hair growth.

Interferon alfa-2a is effective for treating cutaneous T cell lymphoma but has significant side effects.

Targeted cancer therapies often cause serious skin problems that need careful management.

Different types of skin cells have unique genetic markers that affect how likely they are to spread cancer.

The document concludes that a better understanding of cell changes during wound healing could improve treatments for chronic wounds and other conditions.

Recombinant cytokine therapy can cause skin reactions ranging from mild to severe.

YAP and TAZ proteins are necessary for the development of two types of skin cancer.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

Hair follicle hyperplasia is common in both benign and malignant skin lymphoproliferative disorders, with a proposed new term "pseudolymphomatous adnexitis."

The document provides advice on how to recognize and treat skin-related side effects of cancer drugs known as EGFR inhibitors.

An enzyme other than TNAP might be responsible for vitamin B-6 metabolism in the skin.

Patients with myotonic dystrophy often have skin problems that suggest early aging and vitamin D issues, and the severity of these problems is linked to their genetic condition and vitamin D levels.

Chemotherapy and cytokine therapy can cause various skin reactions, including hair loss and hypersensitivity.

The article concludes that hair loss is a common side effect of drugs treating skin cancer by blocking the hedgehog pathway, but treatment should continue, and more selective drugs might prevent this side effect.

New targeted cancer drugs can cause skin side effects, and managing them requires patient education and timely care.

Chemotherapy and radiotherapy can cause skin side effects like rashes, hair loss, and nail changes, which are usually managed with conservative treatments.

Capivasertib improves survival in certain breast cancer cases but requires careful management of side effects.

Skin issues can indicate immune system problems.

Patients with certain skin symptoms and high ANA titers should be monitored for potential systemic lupus.

Lupus can cause different skin problems, and treatments like quitting smoking and using certain creams or medicines can help.

Vaping may harm skin health by causing inflammation.

Electric pulse treatments for breast cancer show promise in being safer and more effective, with fewer side effects.

In Italian patients with lupus, the most common skin issue was chronic cutaneous lupus, especially discoid lesions, and nonspecific skin problems occurred in about a third of those with systemic lupus, mainly during active disease.

Human skin can make serotonin and melatonin, which help protect and maintain it.